CJC-1295 / Ipamorelin

CJC-1295 No DAC / Ipamorelin is a research-grade peptide blend commonly studied for its role in growth hormone signaling pathways. CJC-1295 No DAC is a modified analog of growth hormone-releasing hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue receptor (GHSR) agonist. Together, these compounds allow researchers to examine both GHRH and ghrelin receptor pathways within controlled laboratory models.

In research settings, this blend is frequently investigated for its potential influence on pulsatile growth hormone release, GH/IGF-1 axis signaling, endocrine regulation, and metabolic pathway activity. Scientific literature continues to explore CJC-1295 No DAC and Ipamorelin in non-human experimental models related to cellular signaling, tissue maintenance, recovery processes, and metabolic function.

For research use only. Not for human or veterinary use.